CN101602741A - 作为γ-分泌酶抑制剂的取代的N-芳基磺酰基杂环胺 - Google Patents

作为γ-分泌酶抑制剂的取代的N-芳基磺酰基杂环胺 Download PDF

Info

Publication number
CN101602741A
CN101602741A CNA200910152119XA CN200910152119A CN101602741A CN 101602741 A CN101602741 A CN 101602741A CN A200910152119X A CNA200910152119X A CN A200910152119XA CN 200910152119 A CN200910152119 A CN 200910152119A CN 101602741 A CN101602741 A CN 101602741A
Authority
CN
China
Prior art keywords
alkyl
aryl
alkylene
substituted
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200910152119XA
Other languages
English (en)
Chinese (zh)
Inventor
H·B·乔西恩
J·W·克拉德
T·A·贝拉
R·徐
李虹美
D·比萨尼斯基
赵志强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN101602741A publication Critical patent/CN101602741A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CNA200910152119XA 2004-06-30 2005-06-28 作为γ-分泌酶抑制剂的取代的N-芳基磺酰基杂环胺 Pending CN101602741A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58401004P 2004-06-30 2004-06-30
US60/584010 2004-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800284229A Division CN101048393A (zh) 2004-06-30 2005-06-28 作为γ－分泌酶抑制剂的取代的N－芳基磺酰基杂环胺

Publications (1)

Publication Number Publication Date
CN101602741A true CN101602741A (zh) 2009-12-16

Family

ID=35783342

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA200910152119XA Pending CN101602741A (zh) 2004-06-30 2005-06-28 作为γ-分泌酶抑制剂的取代的N-芳基磺酰基杂环胺
CNA2005800284229A Pending CN101048393A (zh) 2004-06-30 2005-06-28 作为γ－分泌酶抑制剂的取代的N－芳基磺酰基杂环胺

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2005800284229A Pending CN101048393A (zh) 2004-06-30 2005-06-28 作为γ－分泌酶抑制剂的取代的N－芳基磺酰基杂环胺

Country Status (13)

Country Link
US (3) US7763613B2 (https=)
EP (1) EP1789404B1 (https=)
JP (1) JP2008505100A (https=)
CN (2) CN101602741A (https=)
AR (1) AR050994A1 (https=)
AT (1) ATE461926T1 (https=)
CA (1) CA2570183A1 (https=)
DE (1) DE602005020156D1 (https=)
ES (1) ES2341560T3 (https=)
MX (1) MX2007000040A (https=)
PE (1) PE20060481A1 (https=)
TW (1) TWI297270B (https=)
WO (1) WO2006004880A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109705052A (zh) * 2019-01-25 2019-05-03 苏州大学 一种制备1,4-二氢噁嗪的方法
CN119060034A (zh) * 2024-09-02 2024-12-03 上海信诺维生物医药有限公司 一种含吡喃取代的吗啉类化合物的制备方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102702044A (zh) * 2006-01-20 2012-10-03 先灵公司 作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物
WO2007092435A2 (en) * 2006-02-07 2007-08-16 Wyeth 11-beta hsd1 inhibitors
WO2007125364A1 (en) * 2006-04-26 2007-11-08 Merck Sharp & Dohme Limited Piperidines and related compounds for treatment of alzheimer’s disease
DK2041181T3 (da) * 2006-06-08 2011-08-29 Helmholtz Zentrum Muenchen Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
WO2009052126A1 (en) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
US20110190269A1 (en) * 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
NZ602312A (en) 2010-03-10 2014-02-28 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04247081A (ja) 1991-02-01 1992-09-03 Takeda Chem Ind Ltd ５員複素環酸アミド類
US5646167A (en) * 1993-01-06 1997-07-08 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamix acids
ES2205166T3 (es) * 1996-02-02 2004-05-01 D. Western Therapeutics Institute Derivados de isoquinolina y medicamento.
HUP0102532A3 (en) * 1998-06-03 2002-06-28 Gpi Nil Holdings Inc Wilmingto Aza-heterocyclic compounds used to treat neurological disorders and hair loss and process for their preparation and pharmaceutical compositions containing them
NZ514453A (en) 1999-02-26 2003-04-29 Merck & Co Inc Novel sulfonamide compounds and uses thereof
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
JP2001261657A (ja) * 2000-03-17 2001-09-26 Yamanouchi Pharmaceut Co Ltd シアノフェニル誘導体
EP1296950A2 (en) 2000-04-20 2003-04-02 NPS Allelix Corp. Aminopiperidines for use as glyt-1 inhibitors
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
US20040102431A1 (en) 2000-09-25 2004-05-27 Christoph Boss Substituted amino-aza-cycloalkanes useful against malaria
AR034390A1 (es) * 2001-08-03 2004-02-25 Schering Corp Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa
US7122675B2 (en) * 2001-08-03 2006-10-17 Schering Corporation Gamma secretase inhibitors
TW200302717A (en) * 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
US20040171614A1 (en) * 2002-02-06 2004-09-02 Schering-Plough Corporation Novel gamma secretase inhibitors
US7256186B2 (en) * 2002-02-06 2007-08-14 Schering Corporation Gamma secretase inhibitors
WO2004101562A2 (en) 2003-05-13 2004-11-25 Schering Corporation Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
JP4247081B2 (ja) 2003-09-24 2009-04-02 三菱電機株式会社 レーザアニール装置のレーザビーム強度モニタ方法とレーザアニール装置
WO2005097768A2 (en) * 2004-04-05 2005-10-20 Schering Corporation Novel gamma secretase inhibitors
US20060035884A1 (en) * 2004-05-20 2006-02-16 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
CN102702044A (zh) * 2006-01-20 2012-10-03 先灵公司 作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109705052A (zh) * 2019-01-25 2019-05-03 苏州大学 一种制备1,4-二氢噁嗪的方法
CN119060034A (zh) * 2024-09-02 2024-12-03 上海信诺维生物医药有限公司 一种含吡喃取代的吗啉类化合物的制备方法
CN119060034B (zh) * 2024-09-02 2026-03-24 上海信诺维生物医药有限公司 一种含吡喃取代的吗啉类化合物的制备方法

Also Published As

Publication number Publication date
MX2007000040A (es) 2007-03-07
US20100093695A1 (en) 2010-04-15
WO2006004880A3 (en) 2007-03-08
TWI297270B (en) 2008-06-01
TW200612928A (en) 2006-05-01
ATE461926T1 (de) 2010-04-15
PE20060481A1 (es) 2006-06-19
WO2006004880A2 (en) 2006-01-12
CN101048393A (zh) 2007-10-03
AR050994A1 (es) 2006-12-13
US7763613B2 (en) 2010-07-27
US7998958B2 (en) 2011-08-16
EP1789404B1 (en) 2010-03-24
HK1099300A1 (en) 2007-08-10
DE602005020156D1 (de) 2010-05-06
ES2341560T3 (es) 2010-06-22
JP2008505100A (ja) 2008-02-21
US20060040936A1 (en) 2006-02-23
EP1789404A2 (en) 2007-05-30
CA2570183A1 (en) 2006-01-12
US20100087425A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
US7998958B2 (en) Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
JP4335532B2 (ja) Ｍｃｈアンタゴニストおよび肥満治療でのそれらの使用
CN115003655B (zh) 环烷基脲衍生物
JP5291623B2 (ja) 新規化合物
HK1247610A1 (en) Piperidine derivatives as nk1 antagonists
CN102164920B (zh) 烷基噻唑氨基甲酸酯衍生物、其制备方法和其作为faah酶抑制剂的用途
WO2014134774A1 (en) Compounds inhibiting leucine-rich repeat kinase enzyme activity
WO2004080966A1 (ja) 含窒素複素環誘導体およびそれらを有効成分とする薬剤
TW201043619A (en) 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
EP2435416A2 (en) Tetrahydropyranochromene gamma secretase inhibitors
CN101970445A (zh) 苯磺酰基-色满、硫代色满、四氢萘和相关γ分泌酶抑制剂
US20250353824A1 (en) 3-phenylpropylamine derivative
TW201030000A (en) (Dihydro) naphthyridinone derivatives as histamine H3 receptor antagonists
KR20110133033A (ko) 모틸린 수용체에 대해 작용제 활성을 가진 옥시인돌 유도체
CA2562138A1 (en) Fused ring nk1 antagonists
CN113121524A (zh) 杂环亚砜亚胺化合物及其中间体、制备方法和应用
HK1099300B (en) Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
KR20260052245A (ko) CCR8(C-C motif chemokine receptor 8) 억제제로서 신규한 화합물 및 이를 포함하는 약학적 조성물
HK40049426A (en) Heterocyclic sulfoximine compound and intermediate thereof, preparation method therefor, and application thereof
CN101014589A (zh) 作为选择性黑色素聚集激素拮抗剂的新型杂环和其用于治疗肥胖症及相关疾病
HK1196353A (en) Compounds useful as inhibitors of choline kinase
AU2015202475A1 (en) Piperidine derivatives as nk1 antagonists
HK1176069A (en) Piperidine derivatives as nk1 antagonists

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20091216